Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Abhishek Kumar Singh is a healthcare entity and medical professional specializing in medical oncology and clinical research. Based in India and registered as a One Person Company (OPC), the entity focuses on providing advanced cancer treatments, including immunotherapy, targeted therapy, and chemotherapy. Dr. Singh is a recognized expert in the management of solid tumors and hematological malignancies, frequently serving as a principal investigator in clinical trials for novel therapeutic agents. The entity operates at the intersection of clinical practice and pharmaceutical research, contributing to the evaluation of new drug modalities and treatment protocols. Through its clinical operations, the entity facilitates patient access to cutting-edge therapies and participates in the broader life sciences ecosystem by generating clinical data and insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Abhishek Kumar Singh.